Low dose radiation for heart failure
Part of Heart & circulation clinical trials.
This trial tests a very low dose of radiation to see if it can improve symptoms in people with heart failure that hasn't gotten better with standard medicines. The radiation is aimed at the heart to reduce inflammation and may help you feel better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have chronic heart failure with reduced pumping function (ejection fraction less than 40%).
- Your heart failure is New York Heart Association class II or III, meaning you have symptoms with mild or moderate activity.
- Your symptoms have not improved despite taking the recommended heart failure medications.
- You have not had radiation therapy to the chest area before.
- You have not had a heart transplant.
- You are not pregnant and, if you could become pregnant, you agree to use contraception during the study.
- You are able to have an MRI (no metal implants or prostheses).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a targeted, low-dose radiation treatment to the heart can improve symptoms and outcomes for people with advanced heart failure who cannot have a heart transplant or a mechanical heart pump. The treatment is given as a one-time procedure and aims to reduce the heart's workload and improve its function.
This trial tests if a low dose of radiation to the heart can help people with advanced heart failure feel better and improve heart function. It is for patients whose heart failure is stable but severe, and who are already on the best medications.
This trial tests if a low dose of radiation to the whole heart can help people with very advanced heart failure. It is for people who have severe symptoms despite maximum medications and are not candidates for a heart pump or transplant.
This trial tests a new way to plan radiation for cancers in the chest area (like lung, esophageal, or thymus cancers) that aims to protect the heart from high doses of radiation. It is for people who need daily radiation for at least three weeks and who are expected to live more than a year.
This study looks at how radiation therapy affects the heart in people being treated for lung, esophageal, or breast cancer. By watching the heart during and after treatment, researchers hope to find ways to lower heart side effects.
This trial tests whether a low dose of radiation therapy can help people whose esophageal cancer has stopped responding to standard first-line treatment (chemotherapy plus immunotherapy). The goal is to see if the radiation can slow down tumor growth and improve outcomes.
Hear when a new Heart Failure - NYHA II - IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.